Skip to main navigation menu Skip to main content Skip to site footer

Characterization of patients with gastric cancer at the San Rafael de Tunja University Hospital, 2015 – 2020

Abstract

Introduction: Gastric cancer is a public health problem with great impact, which reached 1,090,000 cases and 769,000 deaths in 2020, worldwide; It is the third cause of death from cancer in the world. Objective: Determine the clinical, pathological and sociodemographic characteristics in patients with gastric cancer admitted at Hospital Universitario San Rafael de Tunja, between 2015 and 2020. Materials and methods: observational, descriptive cross-sectional study. From the records of the Hospital Universitario San Rafael de Tunja, there were reviewed medical records of 138 patients, admitted with a diagnosis of gastric carcinoma, in the period 2015 - 2020. Results: mean age 61.7 years, 63.4% men; 52.7% from rural areas; 25% with nutritional deficit due to body mass indexless than 18; 59.4% already had metastases, the most frequent to the Peritoneum, liver and lung; It was only possible to treated surgically in 25.5% of the cases; At the time of evaluation of the medical records, 43.5% of the patients had died. Conclusions: Environmental, cultural and socioeconomic conditions generate favorable scenarios for an increase in the incidence of adenocarcinoma-type gastric cancer, which leads to predicting a progressive increase in them. It is advisable to establish diagnostic and training protocols to enhance early diagnosis, which makes surgery a more effective curative option and improves the prognosis of patients. It would be advisable for a cancer observatory center to be structured at the regional level to carry out epidemiological surveillance and georeferencing of cases to improve monitoring and control conditions.

 

 

Keywords

Adenocarcinoma, Gastrectomy, Prevalence, Neoplasic metastasis

PDF (Español)

Author Biography

Dary Luz Hernández Perilla

MD. Cirujana oncóloga del Instituto Nacional de Cancerología y la Universidad Militar. Esp. Cirugía General. Docente Escuela de Medicina Universidad Pedagógica y Tecnológica de Colombia.

David Leonardo Ortiz Cruz

Médico Interno Universidad Pedagógica y Tecnológica de Colombia.

Laura Victoria Ospina Ariza

MD Maestrante en Terapia Neural Universidad Nacional de Colombia

Juan Manuel Ospina Diaz

MD MSc Epidemiología. Profesor Titular Escuela de Medicina Universidad Pedagógica y Tecnológica de Colombia.


References

  1. Ajani, J., Amico, T., Bentrem, D., Chao, J., Cooke, D., Corvera, C., Fanta, P. (2022). Cáncer gástrico, versión 2.2022, Guías de práctica clínica en oncología de la NCCN. J Natl Compr Canc Netw, 20(2), 167-192. Disponible en: https://jnccn.org/view/journals/jnccn/20/2/articlep167.xml?ArticleBodyColorStyles=inline%20pdf
  2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86.
  3. http://doi.wiley.com/10.1002/ijc.29210
  4. Aaron P. Thrift, Hashem B. El-Serag. Burden of Gastric Cancer. Clinical Gastroenterology and Hepatology 2020; 18:534-542.
  5. Instituto Nacional de Cancerología ESE. Análisis de la situación del cáncer en Colombia 2015. Primera edición. Bogotá, D.C.: Instituto Nacional de Cancerología ESE; 2017. Disponible en: https://www.cancer.gov.co/Situacion_del_Cancer_en_Colombia_2015.pdf
  6. Oliveros R, Navarrera LF. Diagnóstico, estadificación y tratamiento del cáncer gástrico en Colombia desde 2004 a 2008 (REGATE-Colombia). Rev Colomb Gastroenterol. 2012; 27:269–74.
  7. Morales Díaz, Mariuska et al. Cáncer gástrico: algunas consideraciones sobre factores de riesgo y Helicobacter pylori. Rev.Med.Electrón. [online]. 2018, vol.40, n.2 [citado 2024-04-14], pp.433-444. Disponible: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S168418242018000200018&lng=es&nrm=iso
  8. Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020 Aug 29; 396(10251):635-648. doi: 10.1016/S0140-6736(20)31288-5. PMID: 32861308.
  9. Johnston FM, Beckman M. Updates on Management of Gastric Cancer. Curr Oncol Rep. 2019 Jun 24;21(8):67. doi: 10.1007/s11912-019-0820-4. PMID: 31236716.
  10. Rueda VP, Duque PA, Ospina LV. Adenocarcinoma gástrico en paciente con exposición constante a nitritos y nitratos en su alimentación. Rev.salud.hist.sanid.on-line 2015; 10(2):58-66. Disponible:
  11. http://agenf.org/ojs1/ojs/index.php/shs/issue/view/5
  12. Santos León, K. M., Astudillo Pinos, D. I. Rodríguez, J. L. López Contreras, F. (2023). Factores de riesgos y manejo quirúrgico del Cáncer Gástrico. Journal of American Health, 6(2), 10. Disponible: https://doi.org/10.37958/jah.v6i2.177
  13. Matta de García VL, De León JL. Caracterización del cáncer gástrico en Guatemala. Rev Científica [Internet]. 2015; 25(2):9-20. Disponible: http://dialnet.unirioja.es/descarga/articulo/5263261.pdf
  14. Caicedo A, Triana AN, Niño C, Medina F, Reyes K. caracterización sociodemográfica y clínica de pacientes diagnosticados con cáncer gástrico en el departamento de Boyacá (Colombia), 2008-2013. Rev.salud.hist.sanid.on-line 2015; 10(3):45-61. http://revistas.uptc.edu.co/revistas/index.php/shs
  15. Ospina, JM. Quintero, DC. Evaluación de la asociación causal entre Helicobacter pylori y cáncer gástrico. IATROS 2007; 4(1): 60-68.

Downloads

Download data is not yet available.

Similar Articles

You may also start an advanced similarity search for this article.